Work

Immune therapy, a double-edged sword for oncolytic viruses

Year: 2019

Type: editorial

Abstract: In recent years, oncolytic viruses (OVs) have emerged as a powerful, targeted immunotherapy with the identification of new viral vectors as well as genetically engineered viral payloads. Owing to t...

Source: Expert Opinion on Biological Therapy

DOI: 10.1080/14712598.2019.1650911

Authors: Ryan M. McCormack, Balveen Kaur

Institution: The University of Texas Health Science Center at Houston

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: Optimizing oncolytic virus therapy for glioblastoma, G4703589772, Enhancing viral oncolysis with vasculostatin gene delivery, Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas

OpenAlex ID: W2966070262

Cites: 16

Cited by: 2

Related to: 10